Pioneering 3D Human Tissues for Drug Discovery

Jan 25 | 2024

Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress

Read More »

Jan 09 | 2024

Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress

Read More »

Dec 06 | 2023

Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results

Read More »